Inhibiting non-hematopoietic cancer with interleukin 6
US8216562B2 · kind B2 · utility
0Cited by
2References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 5, 2011 |
| Grant date | Jul 10, 2012 |
| Priority date | — |
| Expiry date | Jul 5, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Use of IL-6 for treating non-hematopoietic cancers, e.g., gp130-negative cancers. Also disclosed is a method for identifying a cancer patient suitable for the IL-6 treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.